Medical Communications

The Association of the British Pharmaceutical Indusxtry (ABPI) has unveiled new data showed that UK industry investment in R&D collaborations …

Polly Moyer reflects on her experiences living with the rare condition mal de debarquement syndrome, and discusses how connecting with …

The latest monthly edition of Pharmafocus, the July/August issue, is available to read for free online now!The UK remains split …

This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …

ImmunoGen has announced that, following an in-depth operational review to “extend the company’s cash runway”, it will be implemented a …

Janssen’s Darzalex (daratumumab) has secured FDA approval in combination with lenalidomide and dexamethasone for the treatment of newly diagnosed multiple …

Dr Scott Gottlieb, who stepped down from his role as the 23rd Commissioner of the FDA earlier this year, has …

Patient centricity, derived from the NHS-driven thinking “no decision about me, without me”, has been adopted by pharma to understand …

Takeda has announced its plans to vacate all staff from its US headquarters in Deerfield, Illinois, by the end of …

An outbreak of the rare contagious bacteria Group A streptococcal (iGAS) infection in Essex, UK, has resulted in 32 cases …

In just over a week, on Wednesday 4 July, Pharmafocus will be collaborating with Healthcare Engagement Solutions firm Within3 to …

Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit …

It’s Friday, and time for another run-down of the week’s most popular articles.

The European Commission has awarded approval to Novo Nordisk’s extended half-life factor VIII therapy Esperoct (turoctocog alfa pegol, N8-GP) for …

Sanofi has announced that plans to reorganise its research and development operations will result in the losses of 466 jobs …